225 related articles for article (PubMed ID: 17879116)
41. Surgical management of the axilla: do intramammary nodes matter?
Pugliese MS; Stempel MM; Cody HS; Morrow M; Gemignani ML
Am J Surg; 2009 Oct; 198(4):532-7. PubMed ID: 19800463
[TBL] [Abstract][Full Text] [Related]
42. Can axillary dissection be avoided in patients with sentinel lymph node metastasis?
Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Fleury T; Smith FP; Petrucci PE; Flax R; Drogula C; Magnant C
J Surg Oncol; 2006 Jun; 93(7):550-8. PubMed ID: 16705723
[TBL] [Abstract][Full Text] [Related]
43. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology.
Osako T; Iwase T; Kimura K; Yamashita K; Horii R; Yanagisawa A; Akiyama F
Cancer; 2011 Oct; 117(19):4365-74. PubMed ID: 21437889
[TBL] [Abstract][Full Text] [Related]
44. The optimal management of the axillae of patients with microinvasive breast cancer in the sentinel lymph node era.
Gray RJ; Mulheron B; Pockaj BA; Degnim A; Smith SL
Am J Surg; 2007 Dec; 194(6):845-8; discussion 848-9. PubMed ID: 18005782
[TBL] [Abstract][Full Text] [Related]
45. Factors affecting false-negative breast sentinel node biopsy in Chinese patients.
Chok KS; Suen DT; Lim FM; Li GK; Kwong A
ANZ J Surg; 2007 Oct; 77(10):866-9. PubMed ID: 17803550
[TBL] [Abstract][Full Text] [Related]
46. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
[TBL] [Abstract][Full Text] [Related]
47. Do bone marrow micrometastases correlate with sentinel lymph node metastases in breast cancer patients?
Trocciola SM; Hoda S; Osborne MP; Christos PJ; Levin H; Martins D; Carson J; Daly J; Simmons RM
J Am Coll Surg; 2005 May; 200(5):720-5; discussion 725-6. PubMed ID: 15848362
[TBL] [Abstract][Full Text] [Related]
48. Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes.
Martin Martinez MD; Veys I; Majjaj S; Lespagnard L; Schobbens JC; Rouas G; Filippov V; Noterman D; Hertens D; Feoli F; Bourgeois P; Durbecq V; Larsimont D; Nogaret JM
Eur J Surg Oncol; 2009 Apr; 35(4):387-92. PubMed ID: 18639429
[TBL] [Abstract][Full Text] [Related]
49. Intraoperative frozen section examination of axillary sentinel lymph nodes in breast cancer.
Grabau DA; Rank F; Friis E
APMIS; 2005 Jan; 113(1):7-12. PubMed ID: 15676009
[TBL] [Abstract][Full Text] [Related]
50. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer.
Papa MZ; Zippel D; Kaufman B; Shimon-Paluch S; Yosepovich A; Oberman B; Sadetzki S
J Surg Oncol; 2008 Nov; 98(6):403-6. PubMed ID: 18683193
[TBL] [Abstract][Full Text] [Related]
51. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer.
Giobuin SM; Kavanagh DO; Myers E; Doherty AO; Quinn CM; Crotty T; Evoy D; McDermott E
Eur J Surg Oncol; 2009 Dec; 35(12):1257-60. PubMed ID: 19497702
[TBL] [Abstract][Full Text] [Related]
52. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
[TBL] [Abstract][Full Text] [Related]
53. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
Coombs N; Chen W; Taylor R; Boyages J
Breast J; 2007; 13(6):593-8. PubMed ID: 17983402
[TBL] [Abstract][Full Text] [Related]
54. The utility of intraoperative evaluation of sentinel lymph nodes in breast cancer.
Pugliese MS; Tickman R; Wang NP; Atwood M; Beatty JD
Ann Surg Oncol; 2007 Mar; 14(3):1024-30. PubMed ID: 17195910
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer.
Wada N; Imoto S; Hasebe T; Ochiai A; Ebihara S; Moriyama N
Jpn J Clin Oncol; 2004 Mar; 34(3):113-7. PubMed ID: 15078905
[TBL] [Abstract][Full Text] [Related]
56. Is routine sentinel lymph node biopsy indicated in women undergoing contralateral prophylactic mastectomy? Magee-Womens Hospital experience.
Soran A; Falk J; Bonaventura M; Keenan D; Ahrendt G; Johnson R
Ann Surg Oncol; 2007 Feb; 14(2):646-51. PubMed ID: 17122987
[TBL] [Abstract][Full Text] [Related]
57. Models for predicting non-sentinel lymph node positivity in sentinel node positive breast cancer: the importance of scoring system.
Unal B; Gur AS; Kayiran O; Johnson R; Ahrendt G; Bonaventura M; Soran A
Int J Clin Pract; 2008 Nov; 62(11):1785-91. PubMed ID: 19143863
[TBL] [Abstract][Full Text] [Related]
58. Lymph nodes in the tail of the breast can be missed in standard axillary dissection.
Williams RN; Jones L; Stotter A
Eur J Surg Oncol; 2009 Mar; 35(3):271-5. PubMed ID: 18407454
[TBL] [Abstract][Full Text] [Related]
59. Value of intraoperative examination of axillary sentinel nodes in carcinoma of the breast.
Schwartz GF; Krill LS; Palazzo JP; Dasgupta A
J Am Coll Surg; 2008 Nov; 207(5):758-62. PubMed ID: 18954790
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathological factors and nomograms predicting nonsentinel lymph node metastases after neoadjuvant chemotherapy in breast cancer patients.
Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
Ann Surg Oncol; 2009 Jul; 16(7):1946-51. PubMed ID: 19408057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
